Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.11 | - |
NAV | ₹12.66 | - |
Fund Started | 08 Apr 2024 | - |
Fund Size | ₹160.07 Cr | - |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
1.11
-
NAV
₹12.66
-
Fund Started
08 Apr 2024
-
Fund Size
₹160.07 Cr
-
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
-
Returns
1 Year | 3.94% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3.94%
-
3 Year
-
-
5 Year
-
-
Holding Analysis
Equity | 100.08% | - |
Cash | -0.08% | - |
Equity
100.08%
-
Cash
-0.08%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Fortis Healthcare Ltd. | 9.94% |
Lupin Ltd. | 8.86% |
Laurus Labs Ltd. | 6.91% |
Aurobindo Pharma Ltd. | 5.94% |
Alkem Laboratories Ltd. | 5.78% |
Glenmark Pharmaceuticals Ltd. | 5.31% |
Mankind Pharma Ltd. | 5.03% |
Biocon Ltd. | 4.17% |
Krishna Institute of Medical Sciences Ltd | 3.31% |
Ipca Laboratories Ltd. | 3.29% |
-
Fund Manager
Name | Kapil Menon | - |
Start Date | 02 Jun 2025 | - |
Name
Kapil Menon
-
Start Date
02 Jun 2025
-
About Fund
Description | The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. | - |
Launch Date | 08 Apr 2024 | - |
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
-
Launch Date
08 Apr 2024
-